Mary Kay Fenton
2009 - Achillion Pharmaceuticals
In 2009, Mary Kay Fenton earned a total compensation of $388.1K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $70,650 |
|---|---|
| Option Awards | $78,138 |
| Salary | $235,500 |
| Other | $3,826 |
| Total | $388,114 |
Fenton received $235.5K in salary, accounting for 61% of the total pay in 2009.
Fenton also received $70.7K in non-equity incentive plan, $78.1K in option awards and $3.8K in other compensation.
Rankings
In 2009, Mary Kay Fenton's compensation ranked 7,640th out of 9,885 executives tracked by ExecPay. In other words, Fenton earned more than 22.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,640 out of 9,885 | 23rd |
Division Manufacturing | 2,853 out of 3,690 | 23rd |
Major group Chemicals And Allied Products | 648 out of 866 | 25th |
Industry group Drugs | 464 out of 638 | 27th |
Industry Pharmaceutical Preparations | 343 out of 446 | 23rd |
Source: SEC filing on April 16, 2012.
Fenton's colleagues
We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2009.
2009
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2009
Milind Deshpande
Achillion Pharmaceuticals
Chief Scientific Officer
2009
Joseph Truitt
Achillion Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2009
Gautam Shah
Achillion Pharmaceuticals
Senior Vice President and Chief Compliance Officer
2009
Elizabeth Olek
Achillion Pharmaceuticals